Piper Sandler Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)
In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...
Barclays Sticks to Their Buy Rating for Teva Pharmaceutical (TEVA)
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price ...
pharmaphorum17h
Orexo exits depression DTx alliance with GAIA
It added that the value of Deprexis on its balance sheet at the end of November was SEK 71 million (around $6.5 million). The Swedish company continues to have rights to two other DTx licensed ...